Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Volume: 371, Issue: 10, Pages: 895 - 905
Published: Sep 4, 2014
Abstract
This open-label, randomized, phase 3 study compared melphalan at a dose of 200 mg per square meter of body-surface area plus autologous stem-cell transplantation with melphalan–prednisone–lenalidomide (MPR) and compared lenalidomide maintenance therapy with no maintenance therapy in patients with newly diagnosed multiple...
Paper Details
Title
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
Published Date
Sep 4, 2014
Volume
371
Issue
10
Pages
895 - 905
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.